LifeScience Clinical & Diagnostic
Leads Biolabs' Opamtistomig Receives China's Priority Review for Advanced Neuroendocrine Cancer
Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced that the biologics license application (BLA) for Op...
July 14, 2026 | News
Pfizer and Astellas Expand FDA Approval of PADCEV Plus Keytruda Across All Muscle-Invasive Bladder Cancer Patients
Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) announced that the U.S. Food and Dru...
July 14, 2026 | News
Mindbeam AI Unveils Generative AI Breakthrough for Safer Next-Generation Pain Therapies
Mindbeam AI, the company focused on next-generation AI infrastructure, announced a new research breakthrough showing how generative AI can accelerate...
July 13, 2026 | News
ACHP Launches Patient Advisory Council to Put Chronic Disease Voices at the Heart of Research
The Alliance of Community Health Plans (ACHP) is amplifying patients' voices on chronic disease research via its newly launched Patient Advisory Council. T...
July 13, 2026 | News
Lynk Pharmaceuticals Doses First Patient in Phase II Trial of Novel Vitiligo Therapy
Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on immune and inflammatory diseases, ...
July 10, 2026 | News
QIAGEN Expands Philippines Presence with Experience Lab and Strategic Distribution Partnership
Partnership with Hamburg Trading Corp to advance applied testing and life science research Serving as a learning hub to empower the next generatio...
July 10, 2026 | News
Healome Therapeutics Raises £2 Million Seed Funding to Advance Eye-Drop Platform for Ocular Surface Diseases
Healome Therapeutics ("Healome"), a University of Birmingham spinout developing a proprietary eye-drop matrix technology for ocular surface diseases, has c...
July 09, 2026 | News
Insilico Medicine Advances AI-Discovered IPF Drug Rentosertib into Phase III Trial
Potentially first-in-class oral TNIK inhibitor advances into late-stage development after milestones marked by vital peer-reviewed papers: the discovery-...
July 09, 2026 | News
LG Chem and OTR Therapeutics Partner to Advance China-Sourced Oncology Assets Globally
OTR Therapeutics, a clinical-stage biotechnology company dedicated to transforming early-stage innovations into globally impactful therapies, today an...
July 09, 2026 | News
Europe Approves TEPKINLY Combination as First Bispecific-Based Second-Line Therapy for Follicular Lymphoma
TEPKINLY® (epcoritamab) plus lenalidomide and rituximab (R2) is the first and only bispecific-based therapy approved in Euro...
July 08, 2026 | News
Ascletis Files Dual US INDs for Ultra-Long-Acting Obesity Therapies Targeting Amylin, GLP-1 and GIP Receptors
ASC36_35 FDC, a once-monthly subcutaneous (SQ) injection co-formulation of ASC36 and ASC35, is a potentially first-in-class drug candidate targeting thre...
July 07, 2026 | News
Arima Genomics Partners with Active Motif to Expand Global Access to Hi-C Research Portfolio
Agreement Part of Arima’s Long-Term Strategy to Focus on Core Diagnostic Platform and Tests Arima Genomics, Inc., a cancer diagnostics com...
July 07, 2026 | News
Abu Dhabi DoH and MIT Koch Institute Partner to Advance AI-Enabled Oncology Research
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, and the MIT – Koch Institute for Integrative...
July 06, 2026 | News
Abbisko and AstraZeneca Partner to Advance Novel Oral IO-TKI Combination for EGFR-Mutant Lung Cancer
Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter, announced that it has entered into a strategic collaboration agreement with AstraZeneca (...
July 03, 2026 | News
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
Editor Picks
